Cora Jones

President and Co-founder

Exit Corporation – Cary, North Carolina

Dr. Cora Jones co-founded Exit Opioids Corporation (Exit) with Cerdi Beltre on February 26, 2019. Dr. Jones serves as President of the non-profit health initiative which was established to connect users and facility providers to create a unique partnership to address treating the opioid crisis effectively. She has demonstrated expertise in a myriad of health-related areas including Health Information Technology, Compliance, Strategic Planning, Data and Analytics, Clinical Patient Care, and Field Research. Her knowledge and experience in these areas are central to the company’s unique platform and approach to the harm reduction and treatment industry.

Dr. Jones vision is to revolutionize awareness of harm reduction efforts in the community and throughout the world by improving the way users connect to available resources within minutes from treatment facilities while also developing relationships with the hospitals and other facilities to reach the patients and family members.

By offering services on a dashboard, users and family members will be able to access resources easier and confidentially. The streamlined approach may also help reduce burnout experienced by social workers and counselors at treatment locations.

“The quality of life is not measured in how much you have but how much you save,” says Dr. Jones. Based on that philosophy, as well as a background in patient care, she built the vision and mission behind Exit – shaping the concept of business performance and profit analysis to meet the needs of the key clients, the users and family members, throughout the US. Unlike the current efforts to improve the opioid crisis, Exit focuses on the gap it takes users typically to find treatment and the time before relapse and to meet the needs of the individual at that moment.

Previously, Dr. Jones worked over eight years in clinical healthcare hospitals including OBGYN MFM (the University of Michigan); Emergency Medicine (St. Mary’s of Saginaw); Cardiovascular Medicine (the University of Michigan); as well as a patient family-centered care advocate. Transferring her clinical knowledge to the private sector, she spent over five years at Truven Health Analytics (Truven) and IBM Watson Health which acquired Truven, contributing in the areas of Medicaid Waste Fraud and Abuse data and analytics. In this role, she discovered that millions of dollars were wasted by opioid abuse and misuse through analytics pitch initiative for increased revenue on client accounts fostering other medical conditions and treatments misuse and abuse. The analytic expertise created new client contracts for products and platforms to investigate other areas of waste. Dr. Jones assisted in building a compliance and federal regulation cultural environment to clinical trials within IBM Watson Health. In 2019, Dr. Jones was hired by SignalPath to leverage her expertise and compliance initiatives as SignalPath's first Compliance Manager to cultivate the compliance culture within the organization.

Dr. Jones earned a doctorate in Health Science Organizational and Behavioral Leadership from A.T. Still University in Arizona, an MHSA from Central Michigan University in Michigan, and a Bachelor of Arts in Sociology, Women’s Studies, and Pre-Medicine focus from the University of Michigan. She is an active member of the American College of Health Care Executives and serves as a board committee member for the North Carolina chapter. She has also presented research and evidence on opioids at behavioral and social science conferences providing insight and awareness to the health professional community on the efforts needed to produce growth and change.

Cerdi Beltre

CEO and Co-founder

Exit Corporation – Cary, North Carolina

As CEO and Co-Founder of Exit Corporation, Cerdi Beltre brings an empathetic view of how to solve the challenges opioid users and their families face when in crisis. She has experienced firsthand the joy that comes from seeing a family member succeed beyond addiction by facilitating access to necessary support - while not enabling them.

Ms. Beltre brings a successful career in clinical research with 20+ years of experience in solving efficiency and operational problems in that space. As the Senior Vice President of Site Support Services at the WIRB-Copernicus Group, Ms. Beltre is responsible for defining and executing a strategy for to make life easier on the sites that conduct clinical research.

Prior to joining the WIRB-Copernicus Group, Ms. Beltre worked for IBM Watson Health as an Offering Leader where she provided leadership and direction for a software product that helped research sites manage their portfolio of studies. She began her clinical research career in one of the largest healthcare systems in the United States; Northwell Health. As the Director, Clinical Research Operations / Administrative Director, Clinical Research Service, she oversaw clinical research operations for the then 19-hospital health system and the Feinstein Institute for Medical Research, which together conducted over 2000 clinical research studies annually. Her and her department’s mission was to facilitate high-quality patient-centered research. Within the 17-year career at Northwell Health, Ms. Beltre held other positions with increasing levels of leadership in operations, ethics and regulatory compliance.

She has served on boards, such as the Association for Clinical Research Professionals (ACRP) New York Metropolitan Chapter, Alliance for Clinical Research Excellence and Safety (ACRES) Global Technology Consortium, Women in BIO Research Triangle Park Chapter, amongst others.

Ms. Beltre earned a BA in psychology from Stony Brook University.